Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A

Biochemical Pharmacology(2020)10.1016/j.bcp.2020.114317Source: DataRank Database

Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A is a research paper published in Biochemical Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)OA: hybridTopics (40)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Shinsaku Kawaguchi,Christian E. Badr ORCID,Daphne R. Mattos ORCID,Ana Ruiz-Sáenz ORCID,Jeffrey Serrill ORCID

Live enrichment

PubMed:33152346 PMC:PMC7781188

NCCIH NIH HHS

Grant: T32 AT010131

NIGMS NIH HHS

Grant: R01 GM132649

FIC NIH HHS

Grant: U01 TW006634

NCI NIH HHS

Grant: R01 CA122216

National Institutes of Health

Grant: 5R01GM132649-02

Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands

National Institutes of Health

Grant: 5T32AT010131-05

Research Training in Natural Product Complementary and Integrative Health

Research Council of Finland

Grant: 330255

Levels of cell fate regulation / Consortium: FateLevels

National Institutes of Health

Grant: 5R01CA122216-05

Understanding resistance to HER family tyrosine kinase inhibitors

Research Council of Finland

Grant: 314672

Structures of Endogenous of Macromolecular Assemblies / Consortium: SEMMA

Research Council of Finland

Grant: 289737

Translocational regulation of protein biogenesis

National Institutes of Health

American Brain Tumor Association

American Foundation for Pharmaceutical Education

Academy of Finland

hybridLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S0006295220305530/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0006295220305530?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006295220305530?httpAccept=text/plain

repositoryhttp://hdl.handle.net/10138/326607

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7781188

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

HumansDepsipeptidesDrug Delivery SystemsCell SurvivalDose-Response Relationship, DrugHEK293 CellsMCF-7 CellsErbB ReceptorsSEC Translocation Channels

Keywords

Signal peptideErbBKinase InhibitorHerCoibamide AApratoxin AERBB RECEPTORSCANCER-THERAPYCell SurvivalEMC OR-01PharmacyFACTOR-RECEPTOR MUTATIONSSUBSTRATEDrug Delivery SystemsSDG 3 - Good Health and Well-beingDepsipeptidesBREAST-CANCERHumansBIOLOGICAL EVALUATIONBiochemistry, cell and molecular biologyDose-Response Relationship, DrugPOTENTTRANSLOCATIONHEK293 CellsMCF-7 CellsPHOSPHATIDYLINOSITOL 3-KINASEEPIDERMAL-GROWTH-FACTORSEC Translocation Channels

Sustainable Development Goals

SDG 3: 3. Good health